Percutaneous transluminal coronary angioplasty for unstable angina
P J de Feyter1, P W Serruys, M vd Brand
1Thoraxcentrum, Erasmus University, Rotterdam, The Netherlands.
Insights
Coronary angioplasty effectively treats refractory angina but carries risks like acute closure due to thrombus. Advanced antiplatelet therapies or local treatments may mitigate these complications for better patient outcomes.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Coronary angioplasty is a key intervention for managing refractory angina.
- High initial success rates are tempered by risks, including acute closure, often linked to thrombus presence.
Purpose of the Study:
- To evaluate the efficacy and safety of coronary angioplasty in specific patient cohorts.
- To identify strategies for mitigating complications associated with the procedure.
Main Methods:
- Analysis of results from selected patient groups undergoing coronary angioplasty.
- Focus on patients with single-vessel disease and preserved left ventricular function.
Main Results:
- Coronary angioplasty demonstrates effectiveness in treating various forms of refractory angina.
- Potential complications include acute closure, possibly due to thrombus, necessitating further research into mitigation strategies.
Conclusions:
- Coronary angioplasty is a viable treatment for specific angina patients.
- Further investigation is required to confirm benefits in patients with multivessel disease or impaired left ventricular function.
Abstract:
Coronary angioplasty is an effective treatment for patients with angina at rest, either refractory or initially stabilized but returning despite pharmacologic treatment, and with early postinfarction angina. The procedure has a high initial success rate, but there is an increased risk of major complications resulting from a higher incidence of acute closure, which may be related to preexisting thrombus. Resolution of this problem may be achieved by the use of more potent antiplatelet treatment, pretreatment with thrombolytic agents, or treatment that can be applied locally (e.g., laser energy, atherectomy) at the site of the unstable plaque. Results in this study have been obtained from selected groups of patients: those with predominantly single-vessel disease and well-preserved left ventricular function. It remains to be determined whether the same benefits can be achieved in patients with multivessel disease or in those who have severely reduced left ventricular function.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:27Angina II: Classification
01:26Angina IV: Management
01:27Peripheral Artery Disease III: Interprofessional Care